Achillion Pharmaceuticals, Inc. (ACHN) Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
5/15/2013 9:24:03 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) to Present at Three Upcoming Investor Conferences
5/9/2013 10:21:06 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) Reports First Quarter 2013 Financial Results
5/7/2013 9:38:36 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) Says Hepatitis C Drug Subdues Virus in 63 Pct of Patients
4/23/2013 7:54:04 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) to Present at Two Upcoming Investor Conferences
3/1/2013 12:15:04 PM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference
1/17/2013 9:12:28 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) Reports Interim Results on ACH-3102
1/7/2013 9:48:56 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) to Present at Two Upcoming Investor Conferences
11/14/2012 7:45:50 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for Study of Liver Diseases
11/12/2012 9:21:56 AM
More...
|
Achillion Pharmaceuticals, Inc. (ACHN) Provides Update on Clinical HCV Development Programs
11/12/2012 7:48:01 AM
More...
|
|